Navigation Links
First Year Results of the AXA Research Fund: Over Euro 13 Million Allocated for Research in 2008
Date:3/24/2009

en's University Belfast)
  • Project dedicated to assessing civil conflict risks (Universitat Autonoma of Barcelona)
  • Project entitled A structural approach to inflation and term structure (EDHEC Business School of Lille)
  • 58 young researchers of promise, working in 13 countries

    • 28 postdoctoral fellowships of Euro 60,000 each
    • 30 doctoral fellowships of Euro 120,000 each

    "The AXA Research Fund chose to help outstanding institutions widen their reach in a sustainable manner, through capital endowments, a tool that is very new to Western Europe," said Ezra Suleiman, president of the Scientific Board. "We wanted to guarantee absolute independence and freedom to the researchers who receive our funding, since they are critical to success. We plan to pursue our action in 2009, and will bolster the international dimension of our investments."

    Information about the AXA Research Fund, in particular that pertaining to the selection criteria and process for researchers and institutions interested in being considered for financial assistance can be found at our website: http://researchfund.axa.com

    About AXA

    AXA Group is a worldwide leader in Financial Protection. AXA's operations are diverse geographically, with major operations in Europe, North America and the Asia/Pacific area. For full year 2008, IFRS revenues amounted to Euro 91.2 billion and IFRS adjusted earnings to Euro 3.7 billion. AXA had Euro 981 billion in assets under management as of December 31, 2008.

    The AXA ordinary share is listed on compartment A of Euronext Paris under the ticker symbol CS (ISIN FR0000120628 - Bloomberg: CS FP - Reuters: AXAF.PA). The American Depository Share is also listed on the NYSE under the
    '/>"/>

    SOURCE AXA Group
    Copyright©2009 PR Newswire.
    All rights reserved

    Page: 1 2 3

    Related medicine technology :

    1. Nobilon Advances First Vaccine Into Human Trials - Intranasal Influenza Vaccine Begins Phase I Clinical Development
    2. CSL Behring Receives Orphan-Drug Exclusivity for RiaSTAP(TM), First and Only Approved Treatment of Acute Bleeding Episodes in Patients with Congenital Fibrinogen Deficiency
    3. First Swiss Patients Treated with the Percutaneous MitraClip(R) System
    4. Terumo Heart, Inc. Reports Clinical Progress in the DuraHeart(TM) U.S. Pivotal Trial as NewYork-Presbyterian Hospital/Columbia University Medical Center Implants First Patient
    5. A First-Line Therapy for Renal Cell Carcinoma that can Increase Overall Survival when Compared with Sutent Would Earn a Higher Patient Share in the United States Than in Europe
    6. IlluminOss Medical Announces First Human Case Utilizing a Unique, New, Minimally Invasive Technology for Fracture Repair is Performed at Medical Hospital del Trabajadar in Santiago, Chile
    7. Rosetta Genomics Reports First Ever In-Vivo Efficacy Data for a Systemic MicroRNA Therapeutic for Liver Cancer
    8. Positive Data From Lung Study May Lead to First FDA Approved Treatment for Pulmonary Fibrosis
    9. Alseres Pharmaceuticals Completes Enrollment in First Stage of the Altropane(R) POET-2 Phase III Program
    10. First U.S. Patients Enrolled in the REALISM Continued Access Study
    11. Human Genome Sciences Begins Delivery of First-in-Class Anthrax Treatment to U.S. Strategic National Stockpile
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:7/2/2015)... , 2. Juli 2015 BGI ... DNA-Screening in Hongkong vom American College of ... Hongkong ist das erste klinische Next-Generation-Sequencing Labor, ... ein CAP-Zertifkat erhält und somit die höchsten ... den bestehenden US FDA - 21 CFR ...
    (Date:7/2/2015)... Wash. , July 2, 2015   BioLife Solutions ... and marketer of proprietary clinical grade cell and tissue ... a related cloud hosted biologistics cold chain management app ... today announced that Seattle Business Magazine has included ... to work for in Washington state ...
    (Date:7/2/2015)... LONDON , July 2, 2015 ... commitment to improving access to HIV treatments   ... a strategic manufacturing agreement to enable production in ... additional source of the dolutegravir active pharmaceutical ingredient (API), and ... the finished product (dolutegravir 50mg, marketed under the name Tivicay®) ...
    Breaking Medicine Technology:BGI erhält Akkreditierung vom College of American Pathologists (CAP) 2BioLife Solutions Named One of the 100 Best Companies to Work For in Washington State 2BioLife Solutions Named One of the 100 Best Companies to Work For in Washington State 3ViiV Healthcare and Desano Pharmaceuticals' Manufacturing Agreement Will Allow Competitive Supply of Dolutegravir in China and Several Developing Countries 2ViiV Healthcare and Desano Pharmaceuticals' Manufacturing Agreement Will Allow Competitive Supply of Dolutegravir in China and Several Developing Countries 3ViiV Healthcare and Desano Pharmaceuticals' Manufacturing Agreement Will Allow Competitive Supply of Dolutegravir in China and Several Developing Countries 4ViiV Healthcare and Desano Pharmaceuticals' Manufacturing Agreement Will Allow Competitive Supply of Dolutegravir in China and Several Developing Countries 5ViiV Healthcare and Desano Pharmaceuticals' Manufacturing Agreement Will Allow Competitive Supply of Dolutegravir in China and Several Developing Countries 6
    ... GAITHERSBURG, Md.--(BUSINESS WIRE)--Apr 17, 2007 - GenVec, ... presented at,the 97th annual meeting of the ... support the use of adenovector systems,to deliver ... lead product candidate, TNFerade(TM) biologic (TNFerade),is an ...
    ... Mass.--(BUSINESS WIRE)--Apr 17, 2007 - Curis, Inc.,(NASDAQ:CRIS), ... targeted,medicines primarily for cancer treatment, today announced ... at the 98th Annual Meeting,of the American ... Curis also disclosed that its April 2005 ...
    Cached Medicine Technology:GenVec Announces New Research at AACR on Selectivity and Mechanism,of Action of TNF-Based Anti-Cancer Therapy 2GenVec Announces New Research at AACR on Selectivity and Mechanism,of Action of TNF-Based Anti-Cancer Therapy 3Curis Announces Hedgehog and Wnt Antagonist Data Presentation at,AACR 2Curis Announces Hedgehog and Wnt Antagonist Data Presentation at,AACR 3Curis Announces Hedgehog and Wnt Antagonist Data Presentation at,AACR 4
    (Date:7/2/2015)... ... July 02, 2015 , ... B. E. Smith, ... retained to lead a national chief executive officer recruitment for Indiana ... the healthcare industry, B. E. Smith has recently placed more than 1,000 healthcare ...
    (Date:7/2/2015)... ... July 02, 2015 , ... After conducting a nationwide ... Regional Medical Center in Yuma, Ariz., has hired Robert Trenschel, DO, as chief ... medical management, Dr. Trenschel will assume his new duties at Yuma Regional Medical Center ...
    (Date:7/2/2015)... ... July 02, 2015 , ... The report summarizes ... manufacturers. The report is a valuable source of guidance and direction for companies ... Chinese market for the Gelatin Capsule industry including capacity, production, production value, cost ...
    (Date:7/2/2015)... ... July 02, 2015 , ... ... is announcing with their launch an intention to partner with companies that share ... on the planet. Their innovative water soluble, Cannabidiol (CBD) formulations, combined with Ayurvedic ...
    (Date:7/2/2015)... ... ... DUI arrests and fatalities spike on the 4th of July. In fact, because of drunk ... comes to being on the road. According to attorney David J. Maloney , the ... highway deaths between 2007 and 2011 were caused by drunk driving over the 4th of ...
    Breaking Medicine News(10 mins):Health News:Indiana Blood Center Retains B. E. Smith to Recruit New Chief Executive Officer 2Health News:Indiana Blood Center Retains B. E. Smith to Recruit New Chief Executive Officer 3Health News:Yuma Regional Medical Center Hires New Chief Executive Officer 2Health News:Yuma Regional Medical Center Hires New Chief Executive Officer 3Health News:Gelatin Capsule Market Outlook & Forecast Report 2015-2020 2Health News:Gelatin Capsule Market Outlook & Forecast Report 2015-2020 3Health News:Gelatin Capsule Market Outlook & Forecast Report 2015-2020 4Health News:New Water Soluble CBD Provides Manufacturers & Distributors a More Effective, Safe, & Cost Efficient Alternative to Traditional CBD Oil 2Health News:New Water Soluble CBD Provides Manufacturers & Distributors a More Effective, Safe, & Cost Efficient Alternative to Traditional CBD Oil 3Health News:Attorney David Maloney Stresses Safety through Sobriety 2
    ... 2 in the morning helped adults lose 65% more weight, ... eggs may help overweight adults lose weight and feel more ... of overweight or obese adults, ages 25 to 60, found ... of a calorie-reduced diet lost 65 percent more weight, had ...
    ... cancer patients and their physicians may make more informed, ... determine probability of recurrence, a research team led by ... Cancer Center reported in the Aug. 12 online issue ... . , The 2,838 women studied were diagnosed with ...
    ... As more people send text messages, repetitive strain injury cases are on ... ... 12 SpinVox, the leader in voice-to-content,messaging, today issued new guidelines to ... of all ages texting furiously at all hours of the day, we,are ...
    ... person with a disability, MINNEAPOLIS, Aug. 12 ... for people with disabilities, is seeking,applications for its ... 1992, the Jacobson Award recognizes the pursuit or,achievement ... with a,physical disability or sensory impairment. The award ...
    ... New study fails to settle question about best treatment ... -- The latest update from a European study that ... a decade leaves the debate about the advantages of ... in survival seen for men who underwent surgery to ...
    ... The Quantum Group,Inc. (Amex: QGP ) ... today that Noel J. Guillama, President &,CEO, will ... Conference at,5:00 p.m. (Pacific) on Monday, August 18, ... Mr. Guillama will give a 23-minute presentation ...
    Cached Medicine News:Health News:Risk assessment plays key role in long-term treatment of breast cancer 2Health News:SpinVox Offers New Guidelines to Prevent Repetitive Strain Injuries 2Health News:SpinVox Offers New Guidelines to Prevent Repetitive Strain Injuries 3Health News:Courage Center Seeks Applications for Judd Jacobson Memorial Award 2Health News:Surgery Helps With Prostate Cancer, Sometimes 2Health News:Surgery Helps With Prostate Cancer, Sometimes 3Health News:The Quantum Group to Present at the Noble Financial Equity Conference 2Health News:The Quantum Group to Present at the Noble Financial Equity Conference 3
    For rotating nucleus during phacoemulsification, Also useful for dislocating the nucleus into the anterior chamber during extracapsular cataract extraction, 45, Blunt, Forked, 9.0mm from end...
    ... has two perforations which enable ... various single or bilateral configurations ... drape has two perforations which ... to various single or bilateral ...
    Angled 45, 9mm from end, Longer design from bend to tip allows for easier placement of viscoelastic to all meridians, Dome shape, extra smooth tip...
    Designed for use in traditional external approach DCRs in pediatric patients & for endoscopic DCRs in adults or children. Lumen 6.0mm long, ID-1.4mm (.12 in); OD-5.0mm (.20 in), Outer flanges 8.0mm ...
    Medicine Products: